Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

$710M Gamble Fails as Celgene Terminates Two Phase III Trials

$
0
0
Celgene is scrapping a latestage Crohn's disease drug it acquired in a $710M deal three years ago following an interim data analysis.

Viewing all articles
Browse latest Browse all 2985

Trending Articles